https://stanfordhealthcare.org/publications/798/798434.html
798434 | Stanford Health Care
PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB [DUR]) IN PATIENTS WITH GLIOBLASTOMA (GBM): RESULTS FOR COHORT B (DUR MONOT
stanfordhealthcare